Cannabis research interagency advisory committee

(a) In general There is established within the Department of Health and Human Services a Cannabis Research Interagency Advisory Committee (referred to in this subsection as the Advisory Committee) for purposes of coordinating— (1) Federal research activities relating to cannabis; and (2) aspects of all Federal programs and activities relating to cannabis research, in order to ensure the adequacy and technical soundness of such programs and activities, to minimize barriers to such programs and activities, to provide for the full communication and exchange of information necessary to maintain adequate coordination of such programs and activities. (b) Members The Advisory Committee established under subsection (a) shall consist of the heads of the following agencies or their designees: (1) The National Institutes of Health. (2) The Centers for Disease Control and Prevention. (3) The Food and Drug Administration. (4) The Substance Abuse and Mental Health Services Administration. (5) The Office of the Assistant Secretary of Health. (6) The Office of Minority Health. (7) The Drug Enforcement Administration. (8) The Alcohol, Tobacco, and Cannabis Tax and Trade Bureau (as so redesignated by section 102 of this Act). (9) The Department of Transportation. (10) Any other agency with subject matter expertise that the Secretary of Health and Human Services determines appropriate to advance research on cannabis. (c) Responsibilities In carrying out its duties under this section, the Advisory Committee shall— (1) monitor cannabis research across all relevant Federal departments and agencies, including coordination of Federal activities with respect to cannabis; (2) develop a summary of advances in cannabis research; (3) identify barriers to conducting or supporting cannabis research; (4) make recommendations to the Secretary of Health and Human Services regarding any appropriate changes to such activities; (5) make recommendations to the Secretary of Health and Human Services regarding public participation in decisions relating to cannabis research, and the process by which public feedback can be better integrated into such decisions; (6) develop a strategic plan for the conduct of, and support for, cannabis research, which shall include— (A) proposed budgetary requirements; and (B) recommendations to ensure that cannabis research of the Department of Health and Human Services and of other Federal departments and agencies are not unnecessarily duplicative; and (7) submit to Congress and the President— (A) an annual update on the summary of advances described in paragraph (2); and (B) an annual update to the strategic plan described in paragraph (5), including any progress made in achieving the goals outlined in such strategic plan.